Sugi Predict

Sugi Predict / Compounds / SCHEMBL24256092

SCHEMBL24256092

SCHEMBL24256092

c1ccc(-c2nc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)c5oc6ccccc6c45)cc3)nc(-c3cccc4c3sc3ccccc34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ PRKDC P78527 2/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ CDC14B O60729 1/20 0.31
▸ CDC14A Q9UNH5 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ LIMK1 P53667 1/20 0.30
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26313053 0.93 ALOX5 (0.32) MAPTALOX5ALDH1A1POLBKDM4E
SCHEMBL23816636 0.88 CDC14B (0.38) MAPTALOX5ALDH1A1POLBKDM4E
SCHEMBL24256475 0.87 MAPT (0.33) MAPTALDH1A1POLBKDM4ENPSR1
SCHEMBL22375903 0.87 PRKDC (0.39) MAPTALOX5ALDH1A1POLBKDM4E
SCHEMBL24255853 0.86 ALDH1A1 (0.35) MAPTALDH1A1POLBKDM4ENPSR1
SCHEMBL25799071 0.85 ALDH1A1 (0.35) MAPTALDH1A1POLBKDM4ENPSR1
SCHEMBL22375906 0.85 PRKDC (0.41) MAPTALOX5ALDH1A1POLBKDM4E
SCHEMBL23821619 0.85 CDC14B (0.37) MAPTALOX5ALDH1A1POLBKDM4E
SCHEMBL22375875 0.85 PRKDC (0.38) MAPTALOX5ALDH1A1POLBKDM4E
SCHEMBL24256263 0.84 ALDH1A1 (0.34) MAPTALOX5ALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 — — US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 — — US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 — — US disclosed
WO-2022035097-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER 엘티소재주식회사 2022-02-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 MAPT 376/4885ALOX5 768/4885ALDH1A1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.